FDAs Guidance for Human Factor Engineering Seminar 2018

  • Check with publisher
  • Published date: March 6, 2018
    • Philadelphia, PA,PA, United States

Overview:
This seminar will explain the implementation of ISO 62366 and the regulatory expectations discussed in the 2016 FDA Guidance for a compliant human factors/ usability program.
The ISO 62366 is an "Consensus" Standard, making it a gold standard for regulatory submissions. We will look at other reference points regarding HF, like AAMI/ANSI HE75:2009 and how HF Engineering include consideration of:
1. Device Users
2. Use Environments and User Interfaces
3. Preliminary Analyses
4. Exploratory HF/Usability Evaluations
5. Hazard Mitigation and Control
We will look at the implication of HFE through Design Controls in the QSR:
• Design input -includes "needs of the user and patient"
• Design validation - "... devices conform to defined user needs and intended uses and shall include testing of production units under actual or simulated use conditions. Design validation shall include software validation and risk analysis ...." [incl. use- related risks]

Why you should attend:

This year FDA published their priority list for the completion of their Guidance documentation. This FDA activity gives us inspection and enforcement insight into the priorities within the agency. Human Factors was in the #3.
Following the implementation of the results of a Human Factors/ Usability study, a validation of the safety and effectiveness of the use of the device must be conducted. This Seminar will help to sort through the confusion of the FDA Guidance and ISO standards and help meet regulatory expectations by demystifying the tasks necessary to build a robust Risk based HF program.

Areas Covered in the Session:

• HF Planning
• Scope of Validation
• Use scenarios
• Step by step HF program development

Who will benefit:

• QA/QC Personnel
• Medical Device Manufacturing
• Software Developers
• Engineering Managers
Location: Philadelphia, PA Date: April 12th & 13th, 2018 and Time: 9:00 AM to 6:00 PM
Venue: DoubleTree by Hilton Philadelphia Airport 4509 Island Avenue, Philadelphia, PA 19153


Price:

Register now and save $200. (Early Bird)
Price: $1,295.00 (Seminar Fee for One Delegate)
Until February 28, Early Bird Price: $1,295.00 From March 01 to April 10, Regular Price: $1,495.00
Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*
Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*
Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901504SEMINAR?april-2018-seo-science-marketplace.org
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel

Result 0 votes
John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Head and Neck Cancers

    Head and Neck Cancers

    Life Sciences Shirley (New York) December 26, 2018 Check with publisher

    Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best vaccine development services for different types of head and neck canc...

  • ZCCHC11/PAPD3  peptide

    ZCCHC11/PAPD3 peptide

    Life Sciences Shirley (New York) December 21, 2018 Check with publisher

    ZCCHC11 is an RNA uridyltransferase (EC 2.7.7.52) that uses UTP to add uridines to the 3-prime end of substrate RNA molecules (Jones et al., 2009 (PubMed 19701194)).(supplied by OMIM, Jan 2011). https://www.creative-diagnostics.com/ZCCHC11-PAPD3-pept...

  • WNT15/WNT9B  peptide

    WNT15/WNT9B peptide

    Life Sciences Shirley (New York) December 21, 2018 Check with publisher

    The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during emb...